Bragina, O. D., Chernov, V. I., Garbukov, E. Y., Doroshenko, A. V., Vorobyeva, A. G., Orlova, A. M., & Tolmachev, V. M. (2021). Possibilities of radionuclide diagnostics of Her2-positive breast cancer using technetium-99m-labeled target molecules. Бюллетень сибирской медицины, 20(1), 23-30. https://doi.org/10.20538/1682-0363-2021-1-23-30
Chicago-referens (17:e uppl.)Bragina, O. D., V. I. Chernov, E. Yu Garbukov, A. V. Doroshenko, A. G. Vorobyeva, A. M. Orlova, och V. M. Tolmachev. "Possibilities of Radionuclide Diagnostics of Her2-positive Breast Cancer Using Technetium-99m-labeled Target Molecules." Бюллетень сибирской медицины 20, no. 1 (2021): 23-30. https://doi.org/10.20538/1682-0363-2021-1-23-30.
MLA-referens (9:e uppl.)Bragina, O. D., et al. "Possibilities of Radionuclide Diagnostics of Her2-positive Breast Cancer Using Technetium-99m-labeled Target Molecules." Бюллетень сибирской медицины, vol. 20, no. 1, 2021, pp. 23-30, https://doi.org/10.20538/1682-0363-2021-1-23-30.
